Mechanisms of berberine (Natural Yellow 18) - Induced mitochondrial dysfunction: Interaction with the adenine nucleotide translocator

Toxicological Sciences

Volumn 105, Issue 2, 2008, Pages 408-417

  Pereira, Cláudia V ^a   Machado, Nuno G ^a   Oliveira, Paulo J ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Adenine nucleotide translocator; Berberine; Mitochondria; Toxicology; Transition pore

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; BERBERINE; BONGKREKIC ACID; CALCIUM ION; CYCLOSPORIN A; OLEIC ACID; OLIGOMYCIN; PROTEIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME INHIBITION; LIVER MITOCHONDRION; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; NONHUMAN; RAT; RESPIRATION DEPRESSION; STRUCTURE ANALYSIS;

ADENOSINE DIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATRACTYLOSIDE; BERBERINE ALKALOIDS; BONGKREKIC ACID; CALCIUM; CELL RESPIRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL SWELLING; OLEIC ACID; OLIGOMYCINS; RATS; RATS, WISTAR; TIME FACTORS; UNCOUPLING AGENTS;

BERBERIDACEAE;

EID: 51849122083     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfn131     Document Type: Article

References (39)

1. Armstrong, J. S. (2006). The role of the mitochondrial permeability transition in cell death. Mitochondrion 6, 225-234.
2. Asai, M., Iwata, N., Yoshikawa, A., Aizaki, Y., Ishiura, S., Saido, T. C., and Maruyama, K. (2007). Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem. Biophys. Res. Commun. 352, 498-502.
3. Barreto, M. C., Pinto, R. E., Atrabaca, J. D., and Pavao, M. L. (2003). Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. Toxicol. Lett. 146, 37-47.
4. Bernardi, P., and Forte, M. (2007). The mitochondrial permeability transition pore. Novartis Found. Symp. 287, 157-164; discussion 164-169.
5. Broekemeier, K. M., Dempsey, M. E., and Pfeiffer, D. R. (1989). Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264, 7826-7830.
6. Ckless, K., Schlotffeldt, J. L., Pasqual, M., Moyna, P., Henriques, J. A., and Wajner, M. (1995). Inhibition of in-vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J. Pharm. Pharmacol. 47, 1029-1031.
7. Crompton, M. (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341(Pt 2), 233-249.
8. Crompton, M., Virji, S., and Ward, J. M. (1998). Cyclophilin-D binds strongly to complexes of the voltage-dependent anion charmet and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258, 729-735.
9. Dairkee, S. H., and Hackett, A. J. (1991). Differential retention of rhodamine 123 by breast carcinoma and normal human mammary tissue. Breast Cancer Res. Treat. 18, 57-61.
10. Davis, S., Weiss, M. J., Wong, J. R., Lampidis, T. J., and Chen, L. B. (1985). Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem. 260, 13844-13850.
11. Gornall, A. G., Bardawill, C. J., and David, M. M. (1949). Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177, 751-766.
12. Hagen, T., Lagace, C. J., Modica-Napolitano, J. S., and Aprille, J. R. (2003). Permeability transition in rat liver mitochondria is modulated by the ATP-Mg/Pi carrier. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G274-G281.
13. Haworth, R. A., and Hunter, D. R. (2000). Control of the mitochondrial permeability transition pore by high-affinity ADP binding at the ADP/ATP translocase in permeabilized mitochondria. J. Bioenerg. Biomembr. 32, 91-96.
14. Heerdt, B. G., Houston, M. A., and Augenlicht, L. H. (2005). The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. Cancer Res. 65 9861-9867.
15. Heerdt, B. G., Houston, M. A., and Augenlicht, L. H. (2006). Growth properties of colonic tumor cells are a function of the intrinsic mitochondrial membrane potential. Cancer Res. 66, 1591-1596.
16. Hong, Y., Hui, S. C., Chan, T. Y., and Hou, J. Y. (2002). Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am. J. Chin. Med. 30, 589-599.
17. Hunter, D. R., and Haworth, R. A. (1979). The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys. 195, 453-459.
18. Juhaszova, M., Wang, S., Zorov, D. B., Nuss, H. B., Gleichmann, M., Mattson, M. P., and Sollott, S. J. (2008). The identity and regulation of the mitochondrial permeability transition pore: Where the known meets the unknown. Ann. N. Y. Acad. Sci. 1123, 197-212.
19. Kamo, N., Muratsugu, M., Hongoh, R., and Kobatake, Y. (1979). Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 49, 105-121.
20. Kaneda, Y., Torii, M., Tanaka, T., and Aikawa, M. (1991). In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Ann. Trop. Med. Parasitol. 85, 417-425.
21. Khailova, L. S., Prikhodko, E. A., Dedukhova, V. I., Mokhova, E. N., Popov, V. N., and Skulachev, V. P. (2006). Participation of ATP/ADP antiporter in oleate- and oleate hydroperoxide-induced uncoupling suppressed by GDP and carboxyatractylate. Biochim. Biophys. Acta 1757, 1324-1329.
22. Letasiova, S., Jantova, S., Cipak, L., and Muckova, M. (2006a). Berberine-antiproliferative activity in vitro and induction of apoptosis/ necrosis of the U937 and B16 cells. Cancer Lett. 239, 254-262.
23. Letasiova, S., Jantova, S., Miko, M., Ovadekova, R., and Horvathova, M. (2006b). Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells. J. Pharm. Pharmacol. 58, 263-270.
24. Letasiova, S., Jantova, S., Muckova, M., and Theiszova, M. (2005). Antiproliferative activity of berberine in vitro and in vivo. Biomed Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 149, 461-463.
25. Lin, S., Tsai, S. C., Lee, C. C., Wang, B. W., Liou, J. Y., and Shyu, K. G. (2004). Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol. Pharmacol. 66, 612-619.
26. Nadakavukaren, K. K., Nadakavukaren, J. J., and Chen, L. B. (1985). Increased rhodamine 123 uptake by carcinoma cells, Cancer Res. 45, 6093-6099.
27. O'Brien, T. M., Oliveira, P. J., and Wallace, K. B. (2008). Inhibition of the adenine nucleotide translocator by N-acetyl perfluorooctane sulfonamides in vitro. Toxicol. Appl. Pharmacol. 227, 184-195.
28. Pereira, G. C., Branco, A. F., Matos, J. A., Pereira, S. L., Parke, D., Perkins, E. L., Serafim, T. L., Sardao, V. A., Santos, M. S., Moreno, A. J., et al. (2007). Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo (5,6-a) quinotizinium] on K1735-M2 mouse melanoma cells: Comparison with direct effects on isolated mitochondrial fractions. J. Pharmacol. Exp. Ther. 323, 636-,649.
29. Ross, M. F., Da Ros, T., Blaikie, F. H., Prime, T. A., Porteous, C. M., SeverinaSkulachev, V. P., II., Kjaergaard, H. G., Smith, R. A., and Murphy, M. P. (2006). Accumulation of lipophilic dications by mitochondria and cells. Biochem. J. 400, 199-208.
30. Serafim, T. L., Oliveira, P. J., Sardao, V. A., Perkins, E., Parke, D., and Holy, J. (2008). Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell fine. Cancer Chemother. Pharmacol. 61, 1007-1018.
31. Shirwaikar, A., Rajendran, K., and Punitha, I. S. (2006). In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol. Pharm. Bull. 29, 1906-1910.
32. Skulachev, V. P. (1991). Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation. FEBS Lett. 294, 158-162.
33. Szabo, I., and Zoratti, M. (1991). The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. J. Biol. Chem. 266, 3376-3379.
34. Taylor, C. T., and Baird, A. W. (1995). Berberine inhibition of electrogenic ion transport in rat colon. Br. J. Pharmacol. 116 2667-2672.
35. Tsai, P. L., and Tsai, T. H. (2004). Hepatobiliary excretion of berberine. Drug Metab. Dispos. 32, 405-412.
36. Turner, N., Li, J. Y., Gosby, A., To, S. W., Cheng, Z., Miyoshi, H., Taketo, M. M., Cooney, G. J., Kraegen, E. W., James, D. E., et al. (2008). Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57, 1414-1419.
37. Vergun, O., and Reynolds, I. J. (2005). Distinct characteristics of Ca(2+)-induced depolarization of isolated brain and liver mitochondria. Biochim. Biophys. Acta 1709, 127-137.
38. Zeng, X., and Zeng, X. (1999). Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed. Chromatogr. 13, 442-444.
39. Zhou, L., Yang, Y., Wang, X., Liu, S., Shang, W., Yuan, G., Li, F., Tang, J., Chen, M., and Chen, J. (2007). Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism 56, 405-412.